Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.
2.

Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex.

Lynch KH, Stothard P, Dennis JJ.

BMC Genomics. 2010 Oct 25;11:599. doi: 10.1186/1471-2164-11-599.

3.

Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia.

Lynch KH, Abdu AH, Schobert M, Dennis JJ.

BMC Genomics. 2013 Aug 27;14:574. doi: 10.1186/1471-2164-14-574.

4.

Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex.

Goudie AD, Lynch KH, Seed KD, Stothard P, Shrivastava S, Wishart DS, Dennis JJ.

BMC Genomics. 2008 Dec 18;9:615. doi: 10.1186/1471-2164-9-615.

5.

The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.

Roszniowski B, Latka A, Maciejewska B, Vandenheuvel D, Olszak T, Briers Y, Holt GS, Valvano MA, Lavigne R, Smith DL, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2016 Oct 21. [Epub ahead of print]

PMID:
27770178
6.

Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia.

Drevinek P, Baldwin A, Dowson CG, Mahenthiralingam E.

BMC Microbiol. 2008 Mar 7;8:44. doi: 10.1186/1471-2180-8-44.

7.

Burkholderia cenocepacia phage BcepMu and a family of Mu-like phages encoding potential pathogenesis factors.

Summer EJ, Gonzalez CF, Carlisle T, Mebane LM, Cass AM, Savva CG, LiPuma J, Young R.

J Mol Biol. 2004 Jun 25;340(1):49-65.

PMID:
15184022
8.

Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.

Lynch KH, Seed KD, Stothard P, Dennis JJ.

J Virol. 2010 Feb;84(3):1276-88. doi: 10.1128/JVI.01843-09.

9.

Genetic and phenotypic diversity in Burkholderia: contributions by prophage and phage-like elements.

Ronning CM, Losada L, Brinkac L, Inman J, Ulrich RL, Schell M, Nierman WC, Deshazer D.

BMC Microbiol. 2010 Jul 28;10:202. doi: 10.1186/1471-2180-10-202.

10.
11.

Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.

Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Minicucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A.

J Clin Microbiol. 2004 Apr;42(4):1491-7.

12.

Identification and onion pathogenicity of Burkholderia cepacia complex isolates from the onion rhizosphere and onion field soil.

Jacobs JL, Fasi AC, Ramette A, Smith JJ, Hammerschmidt R, Sundin GW.

Appl Environ Microbiol. 2008 May;74(10):3121-9. doi: 10.1128/AEM.01941-07.

13.

Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum.

Drevinek P, Holden MT, Ge Z, Jones AM, Ketchell I, Gill RT, Mahenthiralingam E.

BMC Infect Dis. 2008 Sep 19;8:121. doi: 10.1186/1471-2334-8-121.

14.

Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.

Sass A, Marchbank A, Tullis E, Lipuma JJ, Mahenthiralingam E.

BMC Genomics. 2011 Jul 22;12:373. doi: 10.1186/1471-2164-12-373.

15.

Identification of an RTX determinant of Burkholderia cenocepacia J2315 by subtractive hybridization.

Whitby PW, VanWagoner TM, Taylor AA, Seale TW, Morton DJ, LiPuma JJ, Stull TL.

J Med Microbiol. 2006 Jan;55(Pt 1):11-21.

PMID:
16388025
16.

Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.

Drevinek P, Mahenthiralingam E.

Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x. Review.

17.

Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.

Carvalho AP, Ventura GM, Pereira CB, Leão RS, Folescu TW, Higa L, Teixeira LM, Plotkowski MC, Merquior VL, Albano RM, Marques EA.

APMIS. 2007 Apr;115(4):311-8.

PMID:
17504297
18.

Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.

Lynch KH, Stothard P, Dennis JJ.

BMC Genomics. 2012 Jun 7;13:223. doi: 10.1186/1471-2164-13-223.

19.

Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia.

Springman AC, Jacobs JL, Somvanshi VS, Sundin GW, Mulks MH, Whittam TS, Viswanathan P, Gray RL, Lipuma JJ, Ciche TA.

Appl Environ Microbiol. 2009 Aug;75(16):5250-60. doi: 10.1128/AEM.00877-09.

20.

Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre.

Golini G, Cazzola G, Fontana R.

Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):175-80.

PMID:
16501927
Items per page

Supplemental Content

Support Center